Newcells provides a quick and accurate in vitro retinal drug toxicity testing service using intricate retinal organoid models created in-house or from client-supplied cells. The retinal toxicity ...
Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this Healio Video Perspective from Telling It Like It Is, Jaclyn L. Kovach, MD, FASRS, overviews ...
The client required a retina model to quickly assess the retinal toxicity of two compounds and identify any differences. Newcells recommended studying how each chemical impacts cell viability and ...
Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating age-related macular degeneration (AMD) fail in some patients. Using that ...
LONDON, LONDON, UNITED KINGDOM, April 15, 2025 /EINPresswire.com/ -- Ms Sharon Heng ,MBBS, PhD, FRCOphth , leading retina specialist at Retina Eye UK has launched ...
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech in a deal that broadens its range of induced pluripotent stem cell‑derived retinal models and reinforces its position in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results